D
Lucid Diagnostics Inc.
LUCD
$1.39
$0.118.59%
D
Sell
2/14/2025Upgraded
Lucid Diagnostics Inc. (LUCD) was upgraded to D- from E+ on 2/14/2025 due to an increase in the solvency index, total return index and volatility index.
Lucid Diagnostics Inc. (LUCD) was upgraded to D- from E+ on 2/14/2025 due to an increase in the solvency index, total return index and volatility index.
E
Sell
3/27/2024Downgrade
Lucid Diagnostics Inc. (LUCD) was downgraded to E+ from D- on 3/27/2024 due to a decline in the solvency index, volatility index and total return index. Debt to equity increased from -1.41 to -0.72.
Lucid Diagnostics Inc. (LUCD) was downgraded to E+ from D- on 3/27/2024 due to a decline in the solvency index, volatility index and total return index. Debt to equity increased from -1.41 to -0.72.
D
Sell
3/15/2024Upgraded
Lucid Diagnostics Inc. (LUCD) was upgraded to D- from E+ on 3/15/2024 due to an increase in the total return index and volatility index.
Lucid Diagnostics Inc. (LUCD) was upgraded to D- from E+ on 3/15/2024 due to an increase in the total return index and volatility index.
E
Sell
2/27/2024Downgrade
Lucid Diagnostics Inc. (LUCD) was downgraded to E+ from D- on 2/27/2024 due to a decline in the volatility index.
Lucid Diagnostics Inc. (LUCD) was downgraded to E+ from D- on 2/27/2024 due to a decline in the volatility index.
D
Sell
2/9/2024Upgraded
Lucid Diagnostics Inc. (LUCD) was upgraded to D- from E+ on 2/9/2024 due to an increase in the total return index and volatility index.
Lucid Diagnostics Inc. (LUCD) was upgraded to D- from E+ on 2/9/2024 due to an increase in the total return index and volatility index.
E
Sell
12/22/2023Downgrade
Lucid Diagnostics Inc. (LUCD) was downgraded to E+ from D- on 12/22/2023 due to a decline in the volatility index.
Lucid Diagnostics Inc. (LUCD) was downgraded to E+ from D- on 12/22/2023 due to a decline in the volatility index.
D
Sell
11/16/2023Upgraded
Lucid Diagnostics Inc. (LUCD) was upgraded to D- from E+ on 11/16/2023 due to a large increase in the growth index, volatility index and total return index. Total revenue increased 392.45% from $159 to $783, and EBIT increased 3.94% from -$11.58M to -$11.13M.
Lucid Diagnostics Inc. (LUCD) was upgraded to D- from E+ on 11/16/2023 due to a large increase in the growth index, volatility index and total return index. Total revenue increased 392.45% from $159 to $783, and EBIT increased 3.94% from -$11.58M to -$11.13M.
E
Sell
3/7/2023Downgrade
Lucid Diagnostics Inc. (LUCD) was downgraded to E+ from D- on 3/7/2023 due to a decline in the volatility index.
Lucid Diagnostics Inc. (LUCD) was downgraded to E+ from D- on 3/7/2023 due to a decline in the volatility index.
D
Sell
2/15/2023Upgraded
Lucid Diagnostics Inc. (LUCD) was upgraded to D- from E+ on 2/15/2023 due to an increase in the volatility index and total return index.
Lucid Diagnostics Inc. (LUCD) was upgraded to D- from E+ on 2/15/2023 due to an increase in the volatility index and total return index.
E
Sell
1/9/2023Downgrade
Lucid Diagnostics Inc. (LUCD) was downgraded to E+ from D- on 1/9/2023 due to a decline in the volatility index.
Lucid Diagnostics Inc. (LUCD) was downgraded to E+ from D- on 1/9/2023 due to a decline in the volatility index.
D
Sell
11/18/2022Upgraded
Lucid Diagnostics Inc. (LUCD) was upgraded to D- from E+ on 11/18/2022 due to a noticeable increase in the growth index and valuation index. Operating cash flow increased 52.3% from -$13.31M to -$6.35M, earnings per share increased from -$0.4089 to -$0.3941, and EBIT increased 1.88% from -$14.62M to -$14.35M.
Lucid Diagnostics Inc. (LUCD) was upgraded to D- from E+ on 11/18/2022 due to a noticeable increase in the growth index and valuation index. Operating cash flow increased 52.3% from -$13.31M to -$6.35M, earnings per share increased from -$0.4089 to -$0.3941, and EBIT increased 1.88% from -$14.62M to -$14.35M.
E
Sell
8/16/2022Downgrade
Lucid Diagnostics Inc. (LUCD) was downgraded to E+ from D- on 8/16/2022 due to a decline in the growth index, solvency index and valuation index. Operating cash flow declined 130.35% from -$5.78M to -$13.31M, EBIT declined 20.89% from -$12.1M to -$14.62M, and earnings per share declined from -$0.3493 to -$0.4089.
Lucid Diagnostics Inc. (LUCD) was downgraded to E+ from D- on 8/16/2022 due to a decline in the growth index, solvency index and valuation index. Operating cash flow declined 130.35% from -$5.78M to -$13.31M, EBIT declined 20.89% from -$12.1M to -$14.62M, and earnings per share declined from -$0.3493 to -$0.4089.
D
Sell
8/15/2022Upgraded
Lucid Diagnostics Inc. (LUCD) was upgraded to D- from E+ on 8/15/2022 due to an increase in the volatility index and total return index.
Lucid Diagnostics Inc. (LUCD) was upgraded to D- from E+ on 8/15/2022 due to an increase in the volatility index and total return index.
E
Sell
7/1/2022Upgraded
Lucid Diagnostics Inc. (LUCD) was upgraded to E+ from E on 7/1/2022 due to a significant increase in the solvency index, volatility index and valuation index.
Lucid Diagnostics Inc. (LUCD) was upgraded to E+ from E on 7/1/2022 due to a significant increase in the solvency index, volatility index and valuation index.
E
Sell
4/1/2022Upgraded
Lucid Diagnostics Inc. (LUCD) was upgraded to E from E- on 4/1/2022 due to an increase in the valuation index.
Lucid Diagnostics Inc. (LUCD) was upgraded to E from E- on 4/1/2022 due to an increase in the valuation index.
E
Sell
1/7/2022None
Lucid Diagnostics Inc. (LUCD) was downgraded to E- from U on 01/07/2022.
Lucid Diagnostics Inc. (LUCD) was downgraded to E- from U on 01/07/2022.
NASDAQ
03/14/2025 1:02PM Eastern
Quotes delayed
